Category: Drug Discovery
Drug Discovery market research reports by GlobalData
-
Uveitis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update
Uveitis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update Summary GlobalData's clinical trial report, “Uveitis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and ... Read More
-
Systemic Sclerosis (Scleroderma) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update
Systemic Sclerosis (Scleroderma) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update Summary GlobalData's clinical trial report, “Systemic Sclerosis (Scleroderma) Clinical Trial Analysis by Trial Phase, Trial Status, Tr ... Read More
-
Autism Spectrum Disorder (ASD) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Autism Spectrum Disorder (ASD) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in ASD therapeutics. There will be over 9.8 million diagnosed prevalent cases of ASD i ... Read More
-
Atrial Fibrillation Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast to 2032
Atrial Fibrillation Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast to 2032 Summary This report covers the 8MM (US, France, Germany, Italy, Spain, UK, Japan, Canada) and provides an ... Read More
-
Atrial Fibrillation Epidemiology Analysis and Forecast to 2032
Atrial Fibrillation Epidemiology Analysis and Forecast to 2032 Summary Atrial fibrillation (AF) is the most common type of cardiac arrhythmia. It occurs due to abnormal electrical activity within the atria of the heart, causing them to fibrillate, and is characterized as a tachyarrhythmia (Wakai and ... Read More
-
Lyme Disease Tests Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast to 2033
Lyme Disease Tests Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast to 2033 Summary Lyme Disease Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model (COVID-19 Market Impact) is built to ... Read More
-
Tourette Syndrome Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update
Tourette Syndrome Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update Summary GlobalData's clinical trial report, “Tourette Syndrome Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status ... Read More
-
Choroidal Neovascularization Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update
Choroidal Neovascularization Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update Summary GlobalData's clinical trial report, “Choroidal Neovascularization Clinical Trial Analysis by Trial Phase, Trial Status, Trial Coun ... Read More
-
Frozen Shoulder Syndrome Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update
Frozen Shoulder Syndrome Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update Summary GlobalData's clinical trial report, “Frozen Shoulder Syndrome Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End ... Read More
-
Dyslipidemia Epidemiology Analysis and Forecast to 2032
Dyslipidemia Epidemiology Analysis and Forecast to 2032 Summary Dyslipidemia is a medical condition characterized by the imbalance of lipids such as cholesterol, low-density lipoprotein cholesterol (LDL-C), triglycerides (TGs), and high-density lipoprotein (HDL) in the blood. Dyslipidemia is a major ... Read More
-
Narcolepsy Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Narcolepsy Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in Narcolepsy therapeutics. There will be more than 900,000 diagnosed prevalent cases of narcolepsy in 202 ... Read More
-
Chronic Low Back Pain (CLBP) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Chronic Low Back Pain (CLBP) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in CLBP therapeutics. There will be more than 344 million prevalent cases of CLBP in 202 ... Read More
-
Rhabdomyosarcoma Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
Rhabdomyosarcoma Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update Summary GlobalData's clinical trial report, “Rhabdomyosarcoma Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, S ... Read More
-
Post-Traumatic Stress Disorder (PTSD) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
Post-Traumatic Stress Disorder (PTSD) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update Summary GlobalData's clinical trial report, “Post-Traumatic Stress Disorder (PTSD) Clinical Trial Analysis by Trial Phase, Trial S ... Read More
-
Alzheimer’s Disease Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast to 2030
Alzheimer’s Disease Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast to 2030 Summary This report covers the 8mm (US, France, Germany, Italy, Spain, UK, Japan, China) and provides an ... Read More
-
Psoriatic Arthritis (PsA) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Psoriatic Arthritis (PsA) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in PsA therapeutics. There will be more than 6 million prevalent cases of PsA in 2023 in th ... Read More
-
Body Dysmorphic Disorder (BDD) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Body Dysmorphic Disorder (BDD) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in BDD therapeutics. There will be 67,698,071 total prevalent cases of BDD in 2023 in ... Read More
-
Amyotrophic Lateral Sclerosis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
Amyotrophic Lateral Sclerosis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update Summary GlobalData's clinical trial report, “Amyotrophic Lateral Sclerosis - Global Clinical Trials Review, 2023 provides an overview of A ... Read More
-
Future of Pharma - Looking Ahead to 2023
Future of Pharma - Looking Ahead to 2023 Summary This report provides a summary of the near and long-term future of the pharmaceutical industry from the standpoint of drug development. It provides a high-level analysis of key trends and movements within the industry via regulatory, clinical, and mar ... Read More
-
Obsessive-Compulsive Disorder (OCD) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Obsessive-Compulsive Disorder (OCD) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive There will be more than 96,921,887 diagnosed prevalent cases of OCD in 2023 in the 16 major ... Read More
-
Myelofibrosis Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast to 2031
Myelofibrosis Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast to 2031 Summary This report covers the 8MM (US, France, Germany, Italy, Spain, UK, Japan, and China) and includes an as ... Read More
-
Hemophilia A (Factor VIII Deficiency) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
Hemophilia A (Factor VIII Deficiency) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update Summary GlobalData's clinical trial report, “Hemophilia A (Factor VIII Deficiency) Clinical Trial Analysis by Trial Phase, Trial S ... Read More
-
Non-Alcoholic Steatohepatitis (NASH) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
Non-Alcoholic Steatohepatitis (NASH) Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update Summary GlobalData's clinical trial report, “Non-Alcoholic Steatohepatitis (NASH) Clinical Trial Analysis by Trial Phase, Trial Sta ... Read More
-
Angelman Syndrome (AS) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Angelman Syndrome (AS) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape Summary This reports provides a data-driven overview of the current and future competitive landscape in AS therapeutics. There will be more than 313,981 diagnosed prevalent cases of AS in 2023 in ... Read More
-
Ulcerative Colitis Epidemiology Analysis and Forecast, 2021-2031
Ulcerative Colitis Epidemiology Analysis and Forecast, 2021-2031 Summary Ulcerative colitis (UC) is an inflammatory bowel disease (IBD) characterized by chronic inflammation and ulcers (sores) in the large intestine, also called the colon and rectum. The inflammation usually begins in the rectum and ... Read More
Research Assistance
